ICICI Prudential Nifty Pharma Index Fund Regular Growth is a mutual fund scheme from ICICI Prudential Asset Management Co Ltd. The fund was launched on 15 December 2022 and is managed by Ashwini Bharucha, Venus Ahuja, and Nishit Patel. As of 13 November 2026, the fund has an AUM of ₹163.10 Cr and its latest NAV is ₹21.55. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹1,000 and lumpsum investment starting from ₹1,000.
The fund primarily invests in Healthcare and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Laurus Labs Ltd, Cipla Ltd, and Dr Reddy's Laboratories Ltd. The fund has delivered 26.2% returns over the last 1 year, 22.0% annualised returns over 3 years, and 22.0% annualised returns since inception.
ICICI Prudential Nifty Pharma Index Fund Regular Growth may be suitable for investors looking for long-term wealth creation and who are comfortable with Very High Risk risk.






